2025-05-06 18:43:24 ET
ACADIA Pharmaceuticals Inc. (ACAD) - Following Earnings Price Analysis was done using last 12 quarters historical earnings.
Opening Gap Moves
Actual Earning Moves
Full story available on KlickAnalytics.com
2025-05-06 18:43:24 ET
ACADIA Pharmaceuticals Inc. (ACAD) - Following Earnings Price Analysis was done using last 12 quarters historical earnings.
Market Wire News is a media platform, the information on this page was provided by KlickAnalytics via Quote Media. Read our full disclaimer.
When you linking your X Account to Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your X account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
ACADIA Pharmaceuticals Inc. Company Name:
ACAD Stock Symbol:
NASDAQ Market:
0.54% G/L:
$22.80 Last:
2,283,690 Volume:
$22.02 Open:
$22.80 Close:
ACADIA Pharmaceuticals Inc. Website:
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on June 6, 2025, the Compensation Committee of Acadia’s Board of Directors (the “Committee”) granted inducement awards consisting of non-qualified stock options to purchase 187,664 shares of common stock and 89,5...
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced it will host a R&D day in New York City to discuss its neurological and rare diseases pipeline on Wednesday, June 25, 2025 at 8:30 AM ET. The event will feature members of Acadia’s management team and R&D organization, ...
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025 at 4:00 p.m. Eastern Time. A live webcast of Acadia’s fireside chat will be accessible on the...